Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2748
Abstract: Pharmacogenomic (PGx) testing has emerged as a compelling strategy that clinicians can use to inform antidepressant medication selection and dosing, but the clinical efficacy of this strategy has been questioned. We systematically reviewed and meta‐analyzed… read more here.
Keywords: clinical trials; depressive symptom; remission; symptom remission ... See more keywords
Neurognitive function and symptom remission 2 years after ECT in major depressive disorders.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2018.12.083
Abstract: BACKGROUND There is a lack of knowledge of possible cognitive side effects of electroconvulsive therapy (ECT) beyond the first few months after treatment. We aim to describe cognitive effects and symptom remission 2 years after… read more here.
Keywords: years ect; remission years; remission; symptom remission ... See more keywords
Genetics of symptom remission in outpatients with COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-90365-6
Abstract: We conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial. We found a significant association… read more here.
Keywords: outpatients covid; genetics symptom; remission; symptom remission ... See more keywords
Five-Year PTSD Symptom Remission in Two Patients Following Treatment With Rivastigmine.
Sign Up to like & getrecommendations! Published in 2022 at "Military medicine"
DOI: 10.1093/milmed/usac094
Abstract: INTRODUCTION The beneficial effect of rivastigmine, an acetylcholinesterase inhibitor (AChEi), which increases levels of acetylcholine (ACh), was first reported in 2013. This paper replicates those findings and reports sustained symptom remission. METHODS AND MATERIALS The… read more here.
Keywords: symptom remission; treatment; ptsd symptom; rivastigmine ... See more keywords
Intra-Individual Variability in Sleep Schedule: Effects of an Internet-Based Cognitive-Behavioral Therapy for Insomnia Program and its Relation with Symptom Remission.
Sign Up to like & getrecommendations! Published in 2020 at "Sleep"
DOI: 10.1093/sleep/zsaa115
Abstract: STUDY OBJECTIVES Sleep schedule consistency is fundamental to cognitive behavioral therapy for insomnia (CBT-I), although there is limited evidence suggesting whether it predicts treatment response. This analysis tested whether: (1) an Internet-based CBT-I program affects… read more here.
Keywords: symptom remission; sleep schedule; insomnia; internet based ... See more keywords